Cutaneous squamous cell carcinoma: from biology to therapy

R Corchado-Cobos, N García-Sancha… - Advances in Surgical …, 2023 - taylorfrancis.com
Cutaneous squamous cell carcinoma (CSCC) is the second most frequent cancer in
humans, with an estimated incidence of 1 million cases each year in the United States …

Identifying candidates for immunotherapy among patients with non-melanoma skin cancer: a review of the potential predictors of response

E Zelin, CA Maronese, A Dri, L Toffoli, N Di Meo… - Journal of Clinical …, 2022 - mdpi.com
Background: Non-melanoma skin cancer (NMSC) stands as an umbrella term for common
cutaneous malignancies, including basal cell carcinoma (BCC) and cutaneous squamous …

Association of patient risk factors, tumor characteristics, and treatment modality with poor outcomes in primary cutaneous squamous cell carcinoma: a systematic …

GA Zakhem, AN Pulavarty, J Carucci… - JAMA …, 2023 - jamanetwork.com
Importance Primary cutaneous squamous cell carcinoma is usually curable; however, a
subset of patients develops poor outcomes, including local recurrence, nodal metastasis …

Multidisciplinary management of locally advanced and metastatic cutaneous squamous cell carcinoma

J Claveau, J Archambault, DS Ernst… - Current …, 2020 - mdpi.com
Multidisciplinary management of locally advanced and metastatic cutaneous squamous cell
carcinoma Page 1 e399 Current Oncology, Vol. 27, No. 4, August 2020 © 2020 Multimed Inc …

Differential expression of PD-L1 between primary and metastatic epithelial ovarian cancer and its clinico-pathological correlation

SK Parvathareddy, AK Siraj, IA Al-Badawi, A Tulbah… - Scientific Reports, 2021 - nature.com
Ovarian cancer (OC) is one of the most common gynecologic cancer, which has the worst
prognosis and highest mortality rate. The lack of curative treatment and the high relapse …

The current treatment landscape of cutaneous squamous cell carcinoma

CY Chong, MS Goh, SV Porceddu, D Rischin… - American Journal of …, 2023 - Springer
Non-melanoma skin cancers (NMSCs) are the most common form of skin cancer worldwide.
The global incidence of cutaneous squamous cell carcinoma (CSCC) is rising, with an …

PD-L1 expression is increased in metastasizing squamous cell carcinomas and their metastases

I García-Díez, E Hernández-Ruiz… - The American Journal …, 2018 - journals.lww.com
Programmed cell death ligand 1 (PD-L1) expression by tumor cells plays an important role
in the inhibition of T cell–mediated immune response in cancer. PD-L1 expression by tumor …

[HTML][HTML] PD-1 and PD-L1 expression predicts radiosensitivity and clinical outcomes in head and neck cancer and is associated with HPV infection

X Lyu, M Zhang, G Li, Y Jiang, Q Qiao - Journal of Cancer, 2019 - ncbi.nlm.nih.gov
Objectives: PD-1 and PD-L1 overexpression in malignant tumors in response to
radiotherapy is correlated with a poor prognosis. Human papilloma virus (HPV) infection …

Prognostic and clinicopathological significance of PD-L1 in patients with bladder cancer: a meta-analysis

L Zhu, J Sun, L Wang, Z Li, L Wang, Z Li - Frontiers in pharmacology, 2019 - frontiersin.org
Background: The prognostic role of programmed cell death-ligand 1 (PD-L1) in bladder
cancer has been investigated in previous studies, but the results remain inconclusive …

Lymph Node Metastases from Non-Melanoma Skin Cancer of the Head and Neck

F Civantos, ZM Helmen, PJ Bradley, A Coca-Pelaz… - Cancers, 2023 - mdpi.com
Simple Summary Skin cancer, particularly non-melanoma skin cancer, is the most common
malignancy in the world. There are both common and uncommon types that receive …